摘要:
A photographic binder prepared by heating a mixed aqueous solution of styrene-maleic anhydride copolymer, isobutylene-maleic anhydride copolymer and polyvinyl alcohol in acidic state makes it possible to coat a photographic coating liquid for forming photographic layers in the same manner as in the case of using gelatin and furthermore gives excellent physical properties to the resultant photographic layers.
摘要:
In one embodiment, there is provided a fuel cell evaluator for evaluating a characteristic of a fuel cell based on a frequency characteristic of impedance of the fuel cell. The evaluator includes: an impedance acquisition unit configured to acquire impedances of the fuel cell for a certain current value in a Tafel region by changing a measurement frequency; an extraction unit configured to extract a reaction resistance from the acquired impedances; a calculator configured to calculate the product of the reaction resistance and the certain current value; and an indicator configured to indicate the product calculated by the calculator as the frequency characteristic of the impedance of the fuel cell.
摘要:
There is provided a secondary battery tester for testing a state of a secondary battery based on an impedance characteristic of the secondary battery. The tester includes: an impedance acquiring section configured to acquire an impedance value of the secondary battery; and a determining section configured to determine a state of a solid electrolyte interface (SEI) layer of the secondary battery based on the impedance value acquired by the impedance acquiring section.
摘要:
Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent for inflammatory bowel disease comprising at least one amino acid selected from the group consisting of lysine, histidine, phenylalanine, methionine, tryptophan, glutamine, glycine, cysteine, cystine and threonine, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day; and a TNF-α production inhibitor comprising an amino acid selected from the group consisting of histidine, phenylalanine and tryptophan, the amino acid being administered at a dose of 0.1 to 4000 mg/kg per day.
摘要:
A marking device includes a marking mechanism, a marking portion moving mechanism, and a pressure adjusting circuit. The marking mechanism marks a surface to be processed, of an object to be marked, by reciprocating a marking portion. The marking portion moving mechanism moves the marking portion in two-dimensional directions along the surface to be processed. The pressure adjusting circuit keeps a constant pressure which the marking portion applies to the surface to be processed. The marking mechanism includes a cam mechanism for linearly reciprocating the marking portion by following a cam which is rotated by a driving member.
摘要:
In one embodiment, there is provided a fuel cell evaluator for evaluating a characteristic of a fuel cell based on a frequency characteristic of impedance of the fuel cell. The evaluator includes: an impedance acquisition unit configured to acquire impedances of the fuel cell for a certain current value in a Tafel region by changing a measurement frequency; an extraction unit configured to extract a reaction resistance from the acquired impedances; a calculator configured to calculate the product of the reaction resistance and the certain current value; and an indicator configured to indicate the product calculated by the calculator as the frequency characteristic of the impedance of the fuel cell.
摘要:
The present invention relates to a therapeutic agent for irritable bowel syndrome of diarrhea type, ulcerative colitis, visceral pain or abdominal pain, which contains a compound of the following formula and which has 5-HT7 receptor antagonistic effect or an analogue thereof; and this therapeutic agent has an excellent therapeutic effect and a high safety:
摘要:
An apparatus and method for accurate measurement of characteristics of optical fibers (distribution of polarization mode dispersion and distribution of magnitude of birefringence). Pulse light is inputted to a subject optical fiber, back scattered light of the pulse light from the subject optical fiber is detected by a photodetector to find a Stokes vector, and polarization mode dispersion in a longitudinal direction is measured. The apparatus comprises a light source unit for outputting the pulse light having at least three different angular frequencies, and an arithmetic operation unit for calculating the magnitude of linear polarization components and the magnitude of a circular polarization component of a polarization dispersion vector on the basis of the Stokes vector and thus calculating polarization mode dispersion.
摘要:
The present invention relates to an ether derivative represented by the formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description, and an ether derivative represented by the formula (III), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description; a pharmaceutical composition containing the ether derivative; and a package containing the pharmaceutical composition and a description of use thereof. A pharmaceutical composition of the present invention, which contains this compound of the present invention has a superior anti-inflammatory and analgesic activity and is useful as various pharmaceutical agents such as an anti-inflammatory agent, an analgesic, a therapeutic agent for inflammatory bowel disease, a therapeutic agent for pollakiuria and/or incontinentia, a therapeutic agent for asthma and the like.
摘要:
The present invention relates to a therapeutic agent for irritable bowel syndrome of diarrhea type, ulcerative colitis, visceral pain or abdominal pain, which contains a compound of the following formula and which has 5-HT7 receptor antagonistic effect or an analogue thereof; and this therapeutic agent has an excellent therapeutic effect and a high safety: